What are the best alternatives if I cannot get Ozempic, and who prescribes them online?

Short answer: There are several medically approved alternatives to Ozempic (semaglutide) — other GLP‑1 drugs (and a newer class, GIP/GLP‑1 agonists), older non‑GLP weight‑loss meds, and device options. These are prescribed by primary care doctors, endocrinologists or obesity‑medicine specialists and by many telehealth / virtual weight‑loss clinics. Below I list common alternatives, why you might choose them, and reputable online services that commonly prescribe weight‑loss and diabetes medicines.

1. GLP‑1 / GIP‑GLP‑1 alternatives

• Wegovy (semaglutide 2.4 mg) — FDA‑approved specifically for chronic weight management (same active ingredient as Ozempic but different dosing). If your problem is access to Ozempic, Wegovy is the direct alternative for weight loss.
• Rybelsus (oral semaglutide) — oral form of semaglutide; useful if you prefer pills or have trouble with injections (dosing and effect differ from injectable semaglutide).
• Zepbound (tirzepatide) — FDA‑approved for weight loss (GIP+GLP‑1 agonist). Has shown larger average weight loss in trials than semaglutide for many people.
• Mounjaro (tirzepatide) — approved for type 2 diabetes; commonly used off‑label for weight loss under specialist care.
• Saxenda (liraglutide) — injectable GLP‑1 approved for weight loss (different dosing schedule than Ozempic).
• Trulicity (dulaglutide) and Victoza (liraglutide) — approved for diabetes; may be options depending on diagnosis and goals.

Why consider these: they work through similar appetite/weight mechanisms (GLP‑1 path), and some (Zepbound/tirzepatide) may produce greater weight loss. Choice depends on whether your primary need is diabetes control or weight management, medical history, side effects, and cost/insurance.

1. Non‑GLP alternatives (if GLP‑1s aren’t appropriate)

• Qsymia (phentermine/topiramate) — prescription weight‑loss pill, effective for many people.
• Contrave (naltrexone/bupropion) — prescription option with a different mechanism.
• Xenical (orlistat prescription) / Alli (orlistat OTC) — reduce fat absorption; modest weight loss but different side‑effect profile.
• Plenity (Gelesis) — non‑systemic, prescription device (capsules) that helps reduce appetite/fullness; prescribed after an online or in‑office evaluation.

Why consider these: If GLP‑1s are unavailable, contraindicated, or too costly, these older options are effective for some patients and may be preferred depending on comorbidities and tolerance.

1. Who prescribes them online (telehealth/virtual services) These types of providers commonly evaluate patients and can prescribe GLP‑1s or alternative weight‑loss/diabetes meds (subject to medical suitability and local regulations):

• Calibrate — specialized weight‑loss telehealth program with physicians/obesity experts; focuses on GLP‑1s plus coaching and metabolic care.
• Ro (Roman) / ZERO (Ro’s weight‑loss offering) — telehealth company that has offered GLP‑1 prescriptions and weight‑loss programs.
• Hims & Hers — telehealth retailer that has provided weight‑loss medication evaluations (offers several med options).
• PlushCare — virtual primary care that can evaluate and prescribe many chronic meds, including diabetes and weight‑loss drugs.
• Teladoc / Amwell — large telemedicine networks; can connect you to PCPs or specialists who may prescribe.
• One Medical — hybrid primary care with virtual visits; can prescribe and help manage these medications.
• GoodRx Care / Honeybee Health / local telehealth clinics — some online clinics will evaluate for weight‑loss meds and handle prescriptions/shipments.
• Manufacturer or pharmacy specialty programs — for Wegovy, Zepbound, etc., the manufacturers have enrollment or patient‑support programs that help with prescriptions and coverage questions.

Important notes and cautions

• You must have a legitimate medical evaluation and prescription. Avoid any online vendor offering these drugs without a clinician visit or prescription — counterfeit or diverted injections are dangerous.
• Some drugs (e.g., Mounjaro) are approved for diabetes but may be prescribed off‑label for weight loss; that should be managed by a clinician familiar with dosing and monitoring.
• Insurance coverage and cost vary widely. Manufacturer patient‑support, prior authorization, and copay assistance programs are common; telehealth vendors can help navigate this.
• Side effects and contraindications (e.g., personal/family medullary thyroid cancer history, pancreatitis risk, pregnancy) mean you should discuss medical history with a prescriber.
• If supply shortages are the reason you can’t get Ozempic, ask your prescriber about switching to Wegovy or another GLP‑1/ GIP/GLP‑1 agent and about transition dosing to limit GI side effects.

If you want, I can:

• Recommend the best alternative for your specific situation (weight‑loss vs diabetes, medical history, insurance).
• Check which of the telehealth services above offers the specific drug you want and help you find a link to their evaluations.
• Draft questions to ask a telehealth clinician when you book an appointment.